Hoenle AG
ISIN: DE0005157101
WKN: 515710
10 December 2025 09:00AM

Original-Research: Hoenle AG (von NuWays AG): BUY

Hoenle AG · ISIN: DE0005157101 · EQS - Analysts
Country: Germany · Primary market: Germany · EQS NID: 24350

Original-Research: Hoenle AG - from NuWays AG

10.12.2025 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.


Classification of NuWays AG to Hoenle AG

Company Name: Hoenle AG
ISIN: DE0005157101
 
Reason for the research: Update
Recommendation: BUY
from: 10.12.2025
Target price: EUR 15.00
Target price on sight of: 12 months
Last rating change:
Analyst: Christian Sandherr

Niche specialist Hoenle offers a unique exposure comprising 50 years of technological leadership in UV curing and one of the largest specialized product portfolios divided into three business units (Adhesive Systems, Curing, Disinfection). Its solutions, featuring customer-centric product design, are key to operational and product excellence for its customers in diversified end markets.

Focus on the right technology. In many cases, UV-based methods (related to adhesives and curing) are superior to others such as heat-based or chemically reactive curing, as their use is faster, cheaper, more environmentally friendly, more flexible and safer for workers as well as end users. Advantages, highly desirable in end markets such as consumer electronics, automotive, medical, food & water purification, printing and surface treatment/converting. Within the respective niches, Hoenle offers the broadest set of products and solutions, making the company a “go-to” player in the rather fragmented market.

Hoenle is market leader in UV curing devices, which can be integrated into various manufacturing environments. For instance, within the printing market, Hoenle’s solutions are used by offset printers (e.g. from Heidelberger Druck or König & Bauer), where high paper throughput demands instant ink drying. Growing market share for its complementary Adhesive Systems, highly tailored for specific use case perks, is the company’s key growth focus. Hoenle also benefits from tailwinds in its powerful Disinfection business unit.

A high degree of innovation across its end markets coupled with the company’s “problem-solver” mentality creates new use cases. Particular attention has been on the ultra-pure water disinfection units (e.g. semi applications) of which first revenues were recognized in FY 2024/2025, deepening the involvement in the automotive sensor market and an improving geographical expansion.

Despite challenging macro environment, stemming from temporary demand contractions, geopolitical uncertainty and changing supply chains in Asia, Hoenle has been taking action to improve its position. It unified its brands into one cohesive brand identity, redesigned its website, discontinued unprofitable business lines, implemented strict cost control and and divested former portfolio companies. This should allow the company to return to growth (eNuW: 6.2% CAGR until 2030) while also notably improving EBITDA (eNuW: 13.9% margin by 2030e).

For FY 2025/2026 a guidance of € 95m to € 105m (1.4-12.1% yoy growth) in sales and € 6m to € 9m EBITDA (6.3-8.6% margin) was issued, implying moderate improvements. In our opinion, this seems feasible as the transformation should begin to bear fruit. The company’s versatile product portfolio is well positioned to adapt effectively to shifting end-market dynamics, partially coinciding with geopolitical uncertainty. Supported by its strong technical expertise, Hoenle looks set to return to growth during the coming years. BUY with an unchanged PT of € 15 (eNuW).
 

You can download the research here: drhonleag20251210multipageren26f9d
For additional information visit our website: https://www.nuways-ag.com/research-feed

Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++


The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2242950  10.12.2025 CET/CEST

Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.

The most important financial data at a glance
  2019 2020 2021 2022 2023 2024 2025e
Sales1 107,75 93,88 115,17 126,50 106,34 98,72 93,70
EBITDA1,2 20,32 14,71 13,85 15,40 0,33 2,97 5,80
EBITDA-Margin3 18,86 15,67 12,03 12,17 0,31 3,01 6,19
EBIT1,4 17,00 8,10 0,35 -10,10 -9,42 -10,26 -5,00
EBIT-Margin5 15,78 8,63 0,30 -7,98 -8,86 -10,39 -5,34
Net Profit (Loss)1 12,40 5,61 -4,86 -11,90 -10,93 -13,00 -6,00
Net-Margin6 11,51 5,98 -4,22 -9,41 -10,28 -13,17 -6,40
Cashflow1,7 23,06 16,61 1,13 -6,00 3,14 5,53 7,00
Earnings per share8 2,26 1,02 -0,80 -2,20 -1,82 -2,19 -1,00
Dividend per share8 0,80 0,50 0,20 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de and Company information
Explanation

1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de

Auditor: RSM Ebner Stolz

All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.

INVESTOR-INFORMATION
©boersengefluester.de
Dr. Hönle
WKN ISIN Legal Type Marketcap IPO Recommendation Plus Code
515710 DE0005157101 AG 41,83 Mio € 24.01.2001 Halten 8FWH4825+66
* * *
PE 2026e PE 10Y-Ø BGFL-Ratio Shiller-PE PB PCF KUV
13,80 18,95 0,73 21,04 0,53 7,56 0,45
Dividends
Dividend '2023
in €
Dividend '2024
in €
Dividend '2025e
in €
Div.-Yield '2025e
in %
0,00 0,00 0,00 0,00%
Financial calendar
Annual General Meeting Q1-figures Q2-figures Q3-figures Annual press conference
24.03.2026 24.02.2026 13.05.2026 07.08.2025 30.01.2026
Performance
Distance 60-days-line Distance 200-days-line Performance YtD Performance 52 weeks IPO
Last Price (EoD)
-4,96%
6,90 €
ATH 89,20 €
-10,31% -20,91% -8,00% -9,69% -42,50%

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
          Qualitätsjournalismus · Made in Germany © 2025          
The news manufactory

Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2025 by Gereon Kruse #BGFL